LB Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LBRX and other ETFs, options, and stocks.About LBRX
LB Pharmaceuticals, Inc. engages in the research and development of novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its product pipeline includes LB-102, is a Phase 3-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms.
CEOHeather D. Turner
CEOHeather D. Turner
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2015
Founded2015
Employees—
Employees—
LBRX Key Statistics
Market cap499.15M
Market cap499.15M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume251.52K
Average volume251.52K
High today$20.72
High today$20.72
Low today$19.13
Low today$19.13
Open price$19.13
Open price$19.13
Volume521.51K
Volume521.51K
52 Week high$23.15
52 Week high$23.15
52 Week low$13.36
52 Week low$13.36
Stock Snapshot
The current LB Pharmaceuticals(LBRX) stock price is $19.86, with a market capitalization of 499.15M.
During the trading session on 2025-12-15, LB Pharmaceuticals(LBRX) shares reached a daily high of $20.72 and a low of $19.13. At a current price of $19.86, the stock is +3.8% higher than the low and still -4.2% under the high.
Trading activity shows a volume of 521.51K, compared to an average daily volume of 251.52K.
The stock's 52-week range extends from a low of $13.36 to a high of $23.15.
The stock's 52-week range extends from a low of $13.36 to a high of $23.15.
People also own
Based on the portfolios of people who own LBRX. This list is generated using Robinhood data, and it’s not a recommendation.